This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Substance Abuse/ Alcoholism  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Mayo-Smith et al¹ have provided an important guideline for the management of alcohol withdrawal delirium in hospitalized patients with alcohol dependence. Based on thorough examination of the literature, they recommend benzodiazepines as the first line of treatment because "these drugs reduce mortality, reduce the duration of symptoms, and are associated with fewer complications compared with neuroleptic agents."¹

As a working group appointed by the Dutch Association of Psychiatry, we developed an evidence-based practice guideline for delirium including alcohol withdrawal delirium.² Contrary to Mayo-Smith et al,¹ we concluded that, in medically ill patients admitted to a general hospital, haloperidol is the first line of treatment for suspected alcohol withdrawal delirium. After all, it is impossible to decide whether delirium was actually caused by alcohol withdrawal and/or by medical illness. Moreover, as Mayo-Smith et al¹ rightly mention, only 5% of patients withdrawing from alcohol develop delirium, raising the risk of overstating the . . . [Full Text of this Article]

AUTHOR INFORMATION
Ine A. M. Klijn, MD; Rose C. van der Mast, MD, PhD

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?